Authors: BAJJOKA I BALIAD P BROWN K MAY E ESCOBAR F MOZES M ABOULJOUD M

Citation: I. Bajjoka et al., INTRAVENOUS VERSUS ORAL GANCICLOVIR IN THE PREVENTION OF CMV INFECTION AND DISEASE IN LIVER-TRANSPLANT RECIPIENTS, Hepatology, 26(4), 1997, pp. 116-116

Authors: ABOULJOUD MS BROWN KA MAY E BALIAD P ESCOBAR FS MOZES MF

Citation: Ms. Abouljoud et al., COST-EFFECTIVE MANAGEMENT OF ACUTE REJECTION IN LIVER-TRANSPLANT RECIPIENTS - A MANAGED CARE PERSPECTIVE, Transplantation proceedings, 29(1-2), 1997, pp. 1557-1559

Authors: ABOULJOUD MS BALIAD P HOCKING N BROWN K MAY E ESCOBAR F MOZES MF

Citation: Ms. Abouljoud et al., MANAGED CARE STRATEGIES IN LIVER-TRANSPLANTATION - IS THERE A CLINICAL BENEFIT, Hepatology, 24(4), 1996, pp. 465-465